R&D and manufacturing sites in Guangzhou, Yulin and other locations support integrated discovery-to-registration capabilities.
3
R&D Sites
200+
R&D Staff
10+
Pipeline Assets
Platform Capabilities
Drug Discovery
Chemistry labs covering target identification, lead optimization and preclinical studies.
CMC & Pilot
Formulation development, process optimization and scale-up for seamless lab-to-plant transfer.
TCM Modernization
Modern pharmaceutical research on classic formulations with upgraded quality standards.
Clinical Operations
Internal and CRO-partnered trial management supporting Phase I–IV clinical research.